Accedi

Bibliografie tematiche / Low molecular weight heparin / Articoli di riviste

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Low molecular weight heparin.

Articoli di riviste sul tema "Low molecular weight heparin"

Autore: Grafiati

Pubblicato: 4 giugno 2021

Ultima modifica: 25 luglio 2025

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Low molecular weight heparin".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.

1

&NA;. "Heparin/low molecular weight heparins." Reactions Weekly &NA;, no. 1414 (2012): 28–29. http://dx.doi.org/10.2165/00128415-201214140-00091.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

&NA;. "Heparin/low-molecular-weight heparins." Reactions Weekly &NA;, no. 1198 (2008): 22. http://dx.doi.org/10.2165/00128415-200811980-00068.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

&NA;. "Heparin/low molecular weight heparins." Reactions Weekly &NA;, no. 1210 (2008): 18. http://dx.doi.org/10.2165/00128415-200812100-00051.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

&NA;. "Heparin/low molecular weight heparins." Reactions Weekly &NA;, no. 1211 (2008): 17–18. http://dx.doi.org/10.2165/00128415-200812110-00053.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

&NA;. "Heparin/low molecular weight heparins." Reactions Weekly &NA;, no. 1211 (2008): 18. http://dx.doi.org/10.2165/00128415-200812110-00056.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

&NA;. "Heparin/low molecular weight heparins." Reactions Weekly &NA;, no. 1277 (2009): 23. http://dx.doi.org/10.2165/00128415-200912770-00068.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

&NA;. "Heparin/low molecular weight heparins." Reactions Weekly &NA;, no. 1231 (2008): 16–17. http://dx.doi.org/10.2165/00128415-200812310-00049.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

&NA;. "Heparin/low molecular weight heparins." Reactions Weekly &NA;, no. 989 (2004): 10. http://dx.doi.org/10.2165/00128415-200409890-00030.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Mulloy, Barbara, Trevor Barrowcliffe, and Elaine Gray. "Heparin and low-molecular-weight heparin." Thrombosis and Haemostasis 99, no. 11 (2008): 807–18. http://dx.doi.org/10.1160/th08-01-0032.

Testo completo

Abstract (sommario):

SummaryHeparin is one of the oldest biological medicines, and has an established place in the prevention and treatment of venous thrombosis. Low-molecular-weight heparins (LMWH) have been developed by several manufacturers and have advantages in terms of pharmacokinetics and convenience of administration. They have been shown to be at least as effective and safe as unfractionated heparin and have replaced the latter in many indications. In this article the chemistry, mechanisms of action, measurement of anticoagulant activities, and clinical status of heparin and LMWH are reviewed.

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Hoppensteadt, Debra, Jeanine M. Walenga, Jawed Fareed, and Rodger L. Bick. "Heparin, low–molecular-weight heparins, and heparin pentasaccharide." Hematology/Oncology Clinics of North America 17, no. 1 (2003): 313–41. http://dx.doi.org/10.1016/s0889-8588(02)00091-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

11

&NA;. "Heparin/low molecular weight heparins/warfarin." Reactions Weekly &NA;, no. 1321 (2010): 20. http://dx.doi.org/10.2165/00128415-201013210-00061.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

12

Hirsh, Jack. "Heparin and low-molecular weight heparins." Coronary Artery Disease 3, no. 11 (1992): 990–1002. http://dx.doi.org/10.1097/00019501-199211000-00002.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

13

&NA;. "Heparin/low-molecular weight heparin." Reactions Weekly &NA;, no. 1216 (2008): 19. http://dx.doi.org/10.2165/00128415-200812160-00049.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

14

Mulloy, B., C. Gee, S. F. Wheeler, R. Wait, E. Gray, and T. W. Barrowcliffe. "Molecular Weight Measurements of Low Molecular Weight Heparins by Gel Permeation Chromatography." Thrombosis and Haemostasis 77, no. 04 (1997): 668–74. http://dx.doi.org/10.1055/s-0038-1656031.

Testo completo

Abstract (sommario):

SummaryThe molecular weight profiles of low molecular weight heparin samples have been measured by high-performance gel permeation chromatography using as calibrant the heparinase-degraded material (90/686) now established as the 1st International Reference Preparation (IRP) Low Molecular Weight Heparin for Molecular Weight Calibration. Use of the calibrant as a broad molecular weight standard is described and a calibration table provided based on data collected over several years in one laboratory.In order to confirm the assignment of degree of polymerisation to resolved oligosaccharide peaks

Gli stili APA, Harvard, Vancouver, ISO e altri

15

Martinez-Salas, José, Richard Mendelssohn, William M. Abraham, Bernard Hsiao, and Tahir Ahmed. "Inhibition of allergic airway responses by inhaled low-molecular-weight heparins: molecular-weight dependence." Journal of Applied Physiology 84, no. 1 (1998): 222–28. http://dx.doi.org/10.1152/jappl.1998.84.1.222.

Testo completo

Abstract (sommario):

Martinez-Salas, José, Richard Mendelssohn, William M. Abraham, Bernard Hsiao, and Tahir Ahmed. Inhibition of allergic airway responses by inhaled low-molecular-weight heparins: molecular-weight dependence. J. Appl. Physiol. 84(1): 222–228, 1998.—Inhaled heparin prevents antigen-induced bronchoconstriction and inhibits anti-immunoglobulin E-mediated mast cell degranulation. We hypothesized that the antiallergic action of heparin may be molecular weight dependent. Therefore, we studied the effects of three different low-molecular-weight fractions of heparin [medium-, low-, and ultralow-molecular

Gli stili APA, Harvard, Vancouver, ISO e altri

16

Barrowcliffe, T. W., A. D. Curtis, E. A. Johnson, and D. P. Thomas. "An International Standard for Low Molecular Weight Heparin." Thrombosis and Haemostasis 60, no. 01 (1988): 001–7. http://dx.doi.org/10.1055/s-0038-1647623.

Testo completo

Abstract (sommario):

SummaryAn international collaborative study has been carried out with the aim of establishing an international standard for low molecular weight (LMW) heparin. Three preparations of LMW heparin were assayed against the International Standard for unfractionated heparin (UFH) by 25 laboratories in 13 countries, using nine different assay methods. The results confirmed previous findings of non-parallel assays, wide interlaboratory variability and differences between methods when LMW heparins are assayed against a UFH standard. Use of one of the LMW heparins as a standard for the other two gave pa

Gli stili APA, Harvard, Vancouver, ISO e altri

17

&NA;. "Danaparoid sodium/heparin/low molecular weight heparins." Reactions Weekly &NA;, no. 1269 (2009): 15–16. http://dx.doi.org/10.2165/00128415-200912690-00042.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

18

&NA;. "Low molecular weight heparins challenge standard heparin." Inpharma Weekly &NA;, no. 805 (1991): 22–23. http://dx.doi.org/10.2165/00128413-199108050-00057.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

19

Fareed, Jawed, Walter Jeske, Daniel Fareed, et al. "Are All Low Molecular Weight Heparins Equivalent in the Management of Venous Thromboembolism?" Clinical and Applied Thrombosis/Hemostasis 14, no. 4 (2007): 385–92. http://dx.doi.org/10.1177/1076029608319881.

Testo completo

Abstract (sommario):

Low molecular weight heparins are replacing unfractionated heparin in a number of clinical indications because of their improved subcutaneous bioavailability and more predictable antithrombotic response. Clinical trials have demonstrated that low molecular weight heparins are at least as safe and effective as unfractionated heparin for the initial treatment of venous thromboembolism, and unfractionated heparin and warfarin for primary and secondary thromboprophylaxis. The mechanism behind the antithrombotic action of low molecular weight heparins is not fully understood but is likely to involv

Gli stili APA, Harvard, Vancouver, ISO e altri

20

Chen, Jianle, Yanlei Yu, Jawed Fareed, et al. "Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin." Clinical and Applied Thrombosis/Hemostasis 25 (January 1, 2019): 107602961984070. http://dx.doi.org/10.1177/1076029619840701.

Testo completo

Abstract (sommario):

Heparin and its low-molecular-weight heparin derivatives are widely used clinical anticoagulants. These drugs are critical for the practice of medicine in applications, including kidney dialysis, cardiopulmonary bypass, and in the management of venous thromboembolism. Currently, these drugs are derived from livestock, primarily porcine intestine and less frequently bovine intestine and bovine lung. The worldwide dependence on the pig as a single dominant animal species has made the supply chain for this critical drug quite fragile, leading to the search for other sources of these drugs, includ

Gli stili APA, Harvard, Vancouver, ISO e altri

21

Hirsh, Jack, and Robert Raschke. "Heparin and Low-Molecular-Weight Heparin." Chest 126, no. 3 (2004): 188S—203S. http://dx.doi.org/10.1378/chest.126.3_suppl.188s.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

22

Hirsh, Jack, Theodore E. Warkentin, Robert Raschke, Christopher Granger, E. Magnus Ohman, and James E. Dalen. "Heparin and Low-Molecular-Weight Heparin." Chest 114, no. 5 (1998): 489S—510S. http://dx.doi.org/10.1378/chest.114.5_supplement.489s.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

23

&NA;. "Low molecular weight heparin." Reactions Weekly &NA;, no. 1148 (2007): 25. http://dx.doi.org/10.2165/00128415-200711480-00081.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

24

Whang, Peter G., and Jay R. Lieberman. "Low-Molecular-Weight Heparin." Journal of the American Academy of Orthopaedic Surgeons 10, no. 5 (2002): 299–302. http://dx.doi.org/10.5435/00124635-200209000-00001.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

25

&NA;. "Low-molecular-weight heparin." Reactions Weekly &NA;, no. 683 (1998): 10. http://dx.doi.org/10.2165/00128415-199806830-00027.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

26

&NA;. "Low molecular weight heparin." Reactions Weekly &NA;, no. 378 (1991): 6. http://dx.doi.org/10.2165/00128415-199103780-00028.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

27

&NA;. "Low molecular weight heparin." Reactions Weekly &NA;, no. 417 (1992): 10. http://dx.doi.org/10.2165/00128415-199204170-00038.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

28

&NA;. "Low molecular weight heparin." Reactions Weekly &NA;, no. 341 (1991): 7. http://dx.doi.org/10.2165/00128415-199103410-00040.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

29

&NA;. "Low molecular weight heparin." Reactions Weekly &NA;, no. 357 (1991): 8. http://dx.doi.org/10.2165/00128415-199103570-00035.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

30

Hirsh, J., and MN Levine. "Low molecular weight heparin." Blood 79, no. 1 (1992): 1–17. http://dx.doi.org/10.1182/blood.v79.1.1.1.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

31

Hirsh, J., and MN Levine. "Low molecular weight heparin." Blood 79, no. 1 (1992): 1–17. http://dx.doi.org/10.1182/blood.v79.1.1.bloodjournal7911.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

32

Hirsh, Jack. "Low Molecular Weight Heparin." Thrombosis and Haemostasis 70, no. 01 (1993): 204–7. http://dx.doi.org/10.1055/s-0038-1646191.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

33

Hirsh, Jack. "Low-Molecular-Weight Heparin." Circulation 98, no. 15 (1998): 1575–82. http://dx.doi.org/10.1161/01.cir.98.15.1575.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

34

Heit, John A. "Low-Molecular-Weight Heparin." Regional Anesthesia and Pain Medicine 23, Sup 2 (1998): 135–39. http://dx.doi.org/10.1097/00115550-199823062-00002.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

35

Routledge, P. A., and R. R. West. "Low molecular weight heparin." BMJ 305, no. 6859 (1992): 906. http://dx.doi.org/10.1136/bmj.305.6859.906.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

36

Horlocker, Terese T., and John A. Heit. "Low Molecular Weight Heparin." Anesthesia & Analgesia 85, no. 4 (1997): 874–85. http://dx.doi.org/10.1097/00000539-199710000-00031.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

37

Hunt, B. J. "Low Molecular Weight Heparin." Blood Coagulation & Fibrinolysis 3, no. 5 (1992): 683. http://dx.doi.org/10.1097/00001721-199210000-00030.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

38

Schmitt, Y., and H. Schneider. "Low molecular weight heparin." Blood Coagulation & Fibrinolysis 7, no. 3 (1996): 385. http://dx.doi.org/10.1097/00001721-199604000-00051.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

39

Horlocker, Terese T., and John A. Heit. "Low Molecular Weight Heparin." Anesthesia & Analgesia 85, no. 4 (1997): 874–85. http://dx.doi.org/10.1213/00000539-199710000-00031.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

40

Wolf, Helmut. "Low-molecular-weight heparin." Medical Clinics of North America 78, no. 3 (1994): 733–43. http://dx.doi.org/10.1016/s0025-7125(16)30155-9.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

41

Nunnelee, Janice D. "Low-molecular-weight heparin." Journal of Vascular Nursing 15, no. 3 (1997): 94–96. http://dx.doi.org/10.1016/s1062-0303(97)90057-1.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

42

Vanpee, Dominique, Jean-Bernard Gillet, and Christian Swine. "Low Molecular Weight Heparin." Annals of Emergency Medicine 36, no. 3 (2000): 277. http://dx.doi.org/10.1067/mem.2000.109264.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

43

Salzman, Edwin W. "Low-Molecular-Weight Heparin." New England Journal of Medicine 315, no. 15 (1986): 957–59. http://dx.doi.org/10.1056/nejm198610093151509.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

44

Gough, S. "Low molecular weight heparin." BMJ 303, no. 6805 (1991): 784. http://dx.doi.org/10.1136/bmj.303.6805.784-a.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

45

Brack, M. J. "Low molecular weight heparin." International Journal of Cardiology 38, no. 2 (1993): 207–8. http://dx.doi.org/10.1016/0167-5273(93)90193-k.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

46

Barrowcliffe, T. W., A. D. Curtis, T. P. Tomlinson, A. R. Hubbard, E. A. Johnson, and D. P. Thomas. "Standardization of Low Molecular Weight Heparins : A Collaborative Study." Thrombosis and Haemostasis 54, no. 03 (1985): 675–79. http://dx.doi.org/10.1055/s-0038-1660095.

Testo completo

Abstract (sommario):

SummaryA collaborative study was carried out, in which eight laboratories each assayed eight low molecular weight (LMW) heparins against the International Standard (IS) for heparin. APTT assays and three types of anti-Xa method were used. The results of this study showed that:1. LMW heparins cannot be validly assayed against the IS by APTT or anti-Xa methods.2. Potencies of LMW heparins vs. the IS differed considerably between the four types of assay method used and also between different laboratories using the same type of method.3. Adoption of a single LMW heparin standard would improve vali

Gli stili APA, Harvard, Vancouver, ISO e altri

47

Shaughnessy, SG, E. Young, P. Deschamps, and J. Hirsh. "The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria." Blood 86, no. 4 (1995): 1368–73. http://dx.doi.org/10.1182/blood.v86.4.1368.bloodjournal8641368.

Testo completo

Abstract (sommario):

Osteoporosis is a well-recognized complication of long-term heparin use. However, the mechanisms by which heparin can influence bone metabolism are unclear. We report here that unfractionated heparin stimulates the process of bone resorption and that the low molecular weight heparins (LMWHs), enoxaparin, fragmin, logiparin, and ardeparin produce significantly less calcium loss than unfractionated heparin. To assess calcium loss from bone, we quantified the release of 45Ca into the culture medium of fetal rat calvaria. 45Ca release was increased in a dose-dependent manner by the addition of eit

Gli stili APA, Harvard, Vancouver, ISO e altri

48

Mammen, Eberhard F. "Low Molecular Weight Heparins and Heparin-Induced Thrombocytopenia." Clinical and Applied Thrombosis/Hemostasis 5, no. 1_suppl (1999): S72—S75. http://dx.doi.org/10.1177/10760296990050s113.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

49

Ambrosioni, E., and E. Strocchi. "Pharmacokinetics of Heparin and Low Molecular Weight Heparins." Pathophysiology of Haemostasis and Thrombosis 20, no. 1 (1990): 94–97. http://dx.doi.org/10.1159/000216165.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

50

Gurfinkel, Enrique P., Jose Santopinto, Gerardo E. Bozovich, Alberto Quispe, Alejandra Strinna, and Branco Mautner. "Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin." American Heart Journal 140, no. 1 (2000): 13A—18A. http://dx.doi.org/10.1067/mhj.2000.106643.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!